Quick Comparison
| NAD+ | NMN | NR | |
|---|---|---|---|
| What it is | The coenzyme itself | Direct precursor, one step from NAD+ | Precursor, one step upstream of NMN |
| Position in pathway | End product | Converts to NAD+ via NMNAT enzymes | Converts to NMN, then to NAD+ |
| Typical administration | IV, intramuscular/subcutaneous injection, or sublingual/nasal delivery | Oral or sublingual capsule/powder | Oral capsule |
| Oral bioavailability | Poor; broken down in digestion | Better than direct NAD+, still needs cellular conversion | Better than direct NAD+, still needs cellular conversion |
| Clinical trial history | Studied mainly via IV/injection protocols | Growing human research base | Longer published human trial track record than NMN |
| Access | Typically requires a clinic or IV provider | Sold as an oral supplement | Sold as an oral supplement (e.g. Niagen) |
What Each One Is
NAD+ (nicotinamide adenine dinucleotide) is the actual coenzyme, not a precursor to something else. It's essential for cellular energy production, it activates sirtuins (proteins linked to cellular repair and longevity pathways), and it supports the enzymes involved in DNA repair. NAD+ levels are well documented to decline with age, which is the underlying reason all three of these approaches exist in the first place.
NMN (nicotinamide mononucleotide) is a direct precursor to NAD+, sitting just one enzymatic conversion step away via NMNAT enzymes. It's usually taken orally or sublingually and has better absorption than NAD+ itself, though the body still has to convert it into active NAD+ once it's inside cells.
NR (nicotinamide riboside) is another NAD+ precursor, positioned one step further upstream than NMN in the same salvage pathway. NR converts to NMN, which then converts to NAD+. NR is also the precursor with the longest track record of published human clinical trial data between the two, and it has been sold commercially, including under the brand name Niagen, for longer than NMN has been on the market.
How They Relate: The Conversion Pathway
The simplest way to picture it is as a short pathway: NR converts to NMN, and NMN converts to NAD+, via the NRK and NMNAT enzyme steps. NAD+ sits at the end of that pathway as the active coenzyme the body actually uses. NAD+ can also be produced through other routes the body uses, such as the Preiss-Handler pathway or synthesis from dietary tryptophan, but the NR-to-NMN-to-NAD+ salvage pathway is the one relevant to these three supplements specifically.
Why this matters: NMN and NR aren't competing with NAD+ so much as feeding into it. Taking NAD+ directly skips the conversion steps but comes with a harder delivery problem, while NMN and NR are easier to take but depend on the body doing the conversion work efficiently, which can vary from person to person.
Human and Preclinical Evidence
NR currently has the longest track record of published human clinical trial data among the two precursors, along with a longer history as a commercial oral supplement (branded as Niagen, used in various supplement products). NMN has a substantial and growing body of human and preclinical research behind it as well, examining its effect on NAD+ levels and downstream markers, though its published human trial history is shorter than NR's. Direct NAD+ administration, typically via IV or injection, has its own separate body of clinical and clinic-based use, distinct from the oral precursor research on NMN and NR.
Across all three, the underlying rationale is the same: NAD+ levels decline with age, and each approach is aimed at supporting or restoring them through a different route.
Regulatory Status
There has been ongoing regulatory and market discussion in the US around NMN's status as a dietary supplement versus other categories. Supplement regulatory status is the kind of thing that can change, so rather than stating a specific current determination here, it's worth checking the current status directly before purchasing NMN, NR, or NAD+ products. NAD+ delivered via IV or injection is a separate access question entirely, since it typically runs through a clinic or provider rather than a retail supplement purchase.
Practical Differences
The practical tradeoff comes down to administration route, convenience, and bioavailability. Direct NAD+, given by IV, intramuscular or subcutaneous injection, or newer sublingual/nasal delivery methods designed to bypass digestion, offers more direct replenishment but a more invasive administration route and access that depends on a clinic or provider. NMN and NR are both oral precursor supplements, far more convenient and accessible than an IV or injection protocol, but they require the body to do the enzymatic conversion work to turn them into active NAD+, and there can be individual variation in how efficiently that conversion happens.
Between NMN and NR specifically, the difference is mainly position in the pathway (NMN is one step closer to NAD+) and track record (NR has the longer published human trial history and longer commercial availability). Neither is inherently superior across the board; they're two entry points into the same conversion route.
Bloodwork and What to Track
There isn't a standardized, routinely available clinical blood test for NAD+ levels the way there is for something like glucose or cholesterol. Specialized NAD+ testing exists in some research and functional-medicine contexts, but it isn't part of a standard clinical panel. For anyone starting an NAD+, NMN, or NR protocol, a more practical approach is establishing a general metabolic baseline with a comprehensive metabolic panel and a lipid panel, then tracking subjective markers like energy and sleep alongside those numbers over time. For a broader look at baseline testing, see the bloodwork guide, which covers a wider panel than NAD+ alone.
Choosing Between Them
If convenience and an oral routine matter most, NMN or NR are the more accessible starting points, with NR carrying the longer published trial history and NMN sitting one conversion step closer to NAD+ itself. If more direct replenishment matters more than convenience, and clinic access isn't a barrier, our NAD+ IV vs oral comparison and NAD+ therapy benefits and cost breakdown go deeper on that route specifically. For a full walkthrough of building out an NAD+-focused protocol, see the best NAD+ supplementation protocol guide. BioStackIQ's Rate My Stack can score a stack that includes any of the three, and Build Protocol can help lay out dosing and timing once a direction is chosen.